Cargando…

Tailored therapy for severe asthma

Patients with severe asthma or COPD have often a suboptimal symptom control due to inadequate treatment. A better understanding of pathogenetic mechanisms, phenotypes, endotypes and the new technologies available in the fields of molecular biology and immunogenetics have made it possible to synthesi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Menzella, Francesco, Lusuardi, Mirco, Galeone, Carla, Zucchi, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323120/ https://www.ncbi.nlm.nih.gov/pubmed/25671117 http://dx.doi.org/10.1186/2049-6958-10-1

Ejemplares similares

The clinical profile of benralizumab in the management of severe eosinophilic asthma
por: Menzella, Francesco, et al.
Publicado: (2016)

Clinical usefulness of mepolizumab in severe eosinophilic asthma
por: Menzella, Francesco, et al.
Publicado: (2016)

Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases
por: Menzella, Francesco, et al.
Publicado: (2015)

Bronchial thermoplasty and the role of airway smooth muscle: are we on the right direction?
por: Menzella, Francesco, et al.
Publicado: (2017)

Near-fatal asthma responsive to mepolizumab after failure of omalizumab and bronchial thermoplasty
por: Menzella, Francesco, et al.
Publicado: (2017)

Recurrent lung atelectasis from fibrin plugs as a very early complication of bronchial thermoplasty: a case report
por: Facciolongo, Nicola, et al.
Publicado: (2015)

Heat-induced necrosis after bronchial thermoplasty: a new concern?
por: Menzella, Francesco, et al.
Publicado: (2018)

Acute respiratory failure as presentation of late-onset Pompe disease complicating the diagnostic process as a labyrinth: a case report
por: Menzella, Francesco, et al.
Publicado: (2018)

Precision Medicine in Targeted Therapies for Severe Asthma: Is There Any Place for “Omics” Technology?
por: Galeone, Carla, et al.
Publicado: (2018)

Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?
por: Menzella, Francesco, et al.
Publicado: (2017)

Severe refractory asthma: current treatment options and ongoing research
por: Menzella, Francesco, et al.
Publicado: (2018)

Immunological Aspects Related to Viral Infections in Severe Asthma and the Role of Omalizumab
por: Menzella, Francesco, et al.
Publicado: (2021)

Long-term benefits of omalizumab in a patient with severe non-allergic asthma
por: Menzella, Francesco, et al.
Publicado: (2011)

Real-life Efficacy of Omalizumab After 9 Years of Follow-up
por: Menzella, Francesco, et al.
Publicado: (2017)

The pharmacoeconomics of the state-of-the-art drug treatments for asthma: a systematic review
por: Menzella, Francesco, et al.
Publicado: (2021)

Nerve ablation after bronchial thermoplasty and sustained improvement in severe asthma
por: Facciolongo, N., et al.
Publicado: (2018)

Targeting eosinophils: severe asthma and beyond
por: Caminati, Marco, et al.
Publicado: (2019)

Towards precision medicine: The application of omics technologies in asthma management
por: Scelfo, Chiara, et al.
Publicado: (2018)

Baseline Characteristics of Patients Enrolled in Clinical Trials of Biologics for Severe Asthma as Potential Predictors of Outcomes
por: Menzella, Francesco
Publicado: (2023)

Bronchial thermoplasty in severe asthma: a real-world study on efficacy and gene profiling
por: Facciolongo, Nicola, et al.
Publicado: (2022)

Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights
por: Menzella, Francesco, et al.
Publicado: (2020)

A Real-World Evaluation of Clinical Outcomes of Biologicals and Bronchial Thermoplasty for Severe Refractory Asthma (BIOTERM)
por: Menzella, Francesco, et al.
Publicado: (2021)

Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance
por: Scelfo, Chiara, et al.
Publicado: (2021)

Real world effectiveness of benralizumab on respiratory function and asthma control
por: Menzella, Francesco, et al.
Publicado: (2021)

Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its competitors?
por: Menzella, Francesco, et al.
Publicado: (2019)

Eosinophilic infiltrate in a patient with severe Legionella pneumonia as a levofloxacin-related complication: a case report
por: Facciolongo, Nicola, et al.
Publicado: (2010)

Comparison between clinical trials and real-world evidence studies on biologics for severe asthma
por: Menzella, Francesco, et al.
Publicado: (2022)

Switching Biological Therapies in Severe Asthma
por: Scioscia, Giulia, et al.
Publicado: (2023)

Omalizumab for the treatment of patients with severe allergic asthma with immunoglobulin E levels above >1500 IU/mL
por: Menzella, Francesco, et al.
Publicado: (2023)

Biologic Therapy and Severe Asthma in Children
por: Russo, Daniele, et al.
Publicado: (2021)

Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review
por: Colombo, Giorgio Lorenzo, et al.
Publicado: (2019)

Management of Patients with Severe Asthma and Chronic Rhinosinusitis with Nasal Polyps: A Multidisciplinary Shared Approach
por: Seccia, Veronica, et al.
Publicado: (2022)

A case of chronic eosinophilic pneumonia in a patient treated with dupilumab
por: Menzella, Francesco, et al.
Publicado: (2019)

“Neurologist's contribution to the diagnosis of sine materia respiratory insufficiency: case report”
por: Carbonelli, Cristiano, et al.
Publicado: (2012)

Tailored therapies for primary immunodeficiencies
por: Cinicola, Bianca, et al.
Publicado: (2021)

Biological therapy for severe asthma
por: Dragonieri, Silvano, et al.
Publicado: (2021)

Swallowing disorders in tracheostomised patients: a multidisciplinary/multiprofessional approach in decannulation protocols
por: Garuti, Giancarlo, et al.
Publicado: (2014)

Real-World Experience with Benralizumab in Patients with Severe Eosinophilic Asthma: A Case Series
por: Menzella, Francesco, et al.
Publicado: (2021)

Use of narrative medicine to identify key factors for effective doctor–patient relationships in severe asthma
por: Cappuccio, Antonietta, et al.
Publicado: (2019)

Successful treatment with benralizumab in a patient with eosinophilic granulomatosis with polyangiitis refractory to mepolizumab
por: Menzella, Francesco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8obs40a6l4mu9ovf0plvq0gdql